SWISS RE LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89 EUR | +0.23% |
|
-.--% | -.--% |
| 04:11pm | SWISS REINSURANCE COMPANY : Gets a Neutral rating from Barclays | ZD |
| 04-22 | Swiss Re to Roll Out AI-Powered Insurance Underwriting Assistant | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Its low valuation, with P/E ratio at 7.84 and 7.17 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Reinsurance
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -.--% | 31.57B | - | ||
| +10.37% | 7.17B | - | ||
| +5.13% | 6.05B | - | - | |
| +12.55% | 5.76B | B | ||
| +0.52% | 4.39B | - | B | |
| +11.61% | 869M | C- | ||
| +19.31% | 675M | - | - | |
| +7.86% | 501M | - | - | |
| +41.80% | 287M | B- | ||
| +5.78% | 152M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SREN Stock
- SR9 Stock
- Ratings Swiss Re Ltd
